“The National Vaccination Committee has done important work during the pandemic. However, its current recommendation for the second booster dose for people aged 30-59 who do not belong to the vulnerable categories is not accompanied by the necessary documentation.” This is what the Health Policy Professor points out in his Facebook post last night Elias Mosialos of the School of Economics and Political Science (LSE) and Imperial College London.
“In particular,” he said, “the committee itself points out ‘that there is currently insufficient scientific data on the additional benefit of a second booster dose with existing vaccines.’ If there is not enough scientific data, then the relevant suggestion should not be made at this time. there is sufficient documentation.
Public health decisions and medical decisions must be based on documentation and systematic data analysis. In our country we need to have sufficient data on the percentage of our compatriots who have adequate immunoprotection. This can be done by random sampling in the general population. “So we can draw safer conclusions about the possible effects of the pandemic in the coming months but also about the need for booster doses.”
Mr. Mosialos also points out that “existing vaccines are still very effective in preventing serious illness. They are no longer very effective in preventing mild infection and re-infections. And this is especially true for subtypes B4 and B5.” of Omicron “.